Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
183.40    -2.40 (-1.29%)
Bid:
182.00
Ask:
184.10
Spread: 2.10 (1.154%)
Market Cap: £811.14m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Segmental Reporting Information

3 Oct 2018 07:00

RNS Number : 7597C
Pets At Home Group Plc
03 October 2018
 

 

FOR IMMEDIATE RELEASE, 3rd October 2018

Pets at Home Group Plc

 

Pets at Home Group Plc, the UK's leading pet care business, today issues prior year unaudited financial information for the H1 FY18 and FY18 period, under the new financial segmentation. This provides a comparable set of financial statements for the upcoming announcement of H1 FY19 interim results on the 27th November 2018.

In FY19, the Group's financial reporting has changed to two segments that represent the size of the respective businesses and our new internal reporting structures; Retail (includes products purchased online and in-store, pet sales, grooming services and insurance products) and Vet Group (includes our First Opinion practices and Specialist Referral Centres).  

 

 

 

Investor Relations Enquiries

Pets at Home Group Plc:

+44 (0)161 486 6688

Amie Gramlick, Director of Investor Relations

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 449 superstores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 468 First Opinion practices located both in our stores and in standalone locations, as well as four Specialist Referral centres. For more information visit: http://investors.petsathome.com/

 

Pets at Home Group Plc, Segmental reporting information for the 52 week period ended 29 March 2018

 

The Group has moved to two reportable segments, Retail and Vet Group, which are the Group's strategic business units for the 52 week period ending 28 March 2019. In the 52 week period ended 29 March 2018, the Group only reported under one segment.

 

Presented below, are the unaudited financial metrics for the 52 week period ending on 28 March 2018, under the new reportable segments.

 

Key Performance Indicators

 

FINANCIALS

Q1 FY18

HY FY18

Q3 FY18

FY18

Revenue

Revenue Split (£m)

Retail

229.2

418.5

202.3

804.8

Vet group

27.3

49.5

21.0

94.1

Total Group

256.5

468.0

223.3

898.9

Revenue Mix (% of total revenues)

Retail

89%

89%

91%

90%

Vet group

11%

11%

9%

10%

Like-for-like growth (%)

Retail like-for-like growth

1.4%

2.8%

6.4% 

4.6%

Vet Group like-for-like growth

17.3%

16.7%

16.9%

15.0%

Total Group like-for-like growth

2.7%

3.9%

7.2%

5.5%

 

Segmental reporting

The Group's operating segments are based on the internal management structure and internal management reports, which are reviewed by the Executive Directors on a periodic basis. The Executive Directors are considered to be the Chief Operating Decision Makers.

 

The Group is a pet care business with the strategic advantage of being able to provide products, services and advice, addressing all pet owners' needs. Within this strategic umbrella, the Group has two reportable segments, Retail and Vet Group, which are the Group's strategic business units, and a central support function. The strategic business units offer different products and services, are managed separately and require different operational and marketing strategies.

 

The operations of the Retail reporting segment comprise the retailing of pet products purchased online and in-store, pet sales, grooming services and insurance products. The operations of the Vet Group reporting segment comprise First Opinion practices and Specialist Referral Centres. Central includes group costs and finance expenses. Revenue and costs are allocated to a segment where reasonably possible.

The following summary describes the operations in each of the Group's reportable segments. Performance is measured based on segment operating profit, as included in the management reports that are reviewed by the Executive Directors. These internal reports are prepared in accordance with IFRS accounting policies consistent with these Group Financial Statements. All material operations of the reportable segments are carried out in the UK and all revenue is from external customers.

 

52 week period ended 29 March 2018

Income Statement - Underlying trading

Retail

£000

Vet Group

£000

Central

£000

Total

£000

Revenue

804,849

94,075

-

898,924

Gross Profit

420,278

44,330

-

464,608

Underlying Operating profit

65,137

29,572

(5,906)

88,803

Non-underlying items

(2,685)

(2,244)

-

(4,929)

Segment operating profit

62,452

27,328

(5,906)

83,874

Net financing expenses

-

-

(4,278)

(4,278)

Profit before tax

62,452

27,328

(10,184)

79,596

Non-underlying items in Retail operating profit in the 52 week period ended 29 March 2018 of £2,685,000 relates to the closure of our seven trial Barkers stores and the associated lease commitments, including disposal of fixed assets. Non-underlying operating items in Vet Group operating profit includes £1,625,000 in relation to the ownership structures and accounting treatment of the Specialist Referral Centres (Dick White Referrals Limited, Eye-Vet Limited and Anderson Moores Veterinary Specialists Limited), where the discounted future value of shares owned by clinician partners is recognised as an expense over the period to which their value can be realised. Other Vet Group non-underlying items includes £619,000 in relation to halted merger and acquisition costs.

 

Vet group Underlying Operating profit is shown net of provisions charged against operating loan funding provided by the Group to First Opinion veterinary practices of £5,673,000 for the 52 week period ended 29 March 2018. This includes £701,000 in relation to balances written off.

 

26 week period ended 12 October 2017

Income Statement - Underlying trading

Retail

£000

Vet Group

£000

Central

£000

Total

£000

Revenue

418,505

49,509

-

468,014

Gross Profit

218,646

24,461

-

243,107

Underlying Operating profit

31,009

16,286

(3,180)

44,115

Non-underlying items

-

(966)

-

(966)

Segment operating profit

31,009

15,320

(3,180)

43,149

Net financing expenses

-

-

(2,370)

(2,370)

Profit before tax

31,009

15,320

(5,550)

40,779

 

Non-underlying operating items in Vet Group operating profit includes £966,000 in relation to the ownership structures and accounting treatment of the Specialist Referral Centres (Dick White Referrals Limited, Eye-Vet Limited and Anderson Moores Veterinary Specialists Limited), where the discounted future value of shares owned by clinician partners is recognised as an expense over the period to which their value can be realised.

Vet group Underlying Operating profit is shown net of provisions charged against operating loan funding provided by the Group to First Opinion veterinary practices of £452,000 for the 26 week period ended 12 October 2017.

52 week period ended 29 March 2018

Reconciliation of EBITDA before Non-Underlying items

Retail

£000

Veterinary

£000

Central

£000

Total

£000

Underlying Operating profit

65,137

29,572

(5,906)

88,803

Depreciation expense

26,306

1,974

-

28,280

Amortisation expense

5,845

358

-

6,203

Underlying EBITDA

97,288

31,904

(5,906)

123,286

26 week period ended 12 October 2017

Reconciliation of EBITDA before Non-Underlying items

Retail

£000

Veterinary

£000

Central

£000

Total

£000

Underlying Operating profit

31,009

16,286

(3,180)

44,115

Depreciation expense

14,005

945

-

14,950

Amortisation expense

2,880

211

-

3,091

Underlying EBITDA

47,894

17,442

(3,180)

62,156

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFMMGGVZMGRZM
Date   Source Headline
17th Sep 20203:05 pmRNSHolding(s) in Company
15th Sep 20204:32 pmRNSHolding(s) in Company
14th Sep 20203:43 pmRNSHolding(s) in Company
26th Aug 20204:47 pmRNSHolding(s) in Company
20th Aug 20202:50 pmRNSHolding(s) in Company
17th Aug 20202:46 pmRNSHolding(s) in Company
14th Aug 20204:00 pmRNSHolding(s) in Company
13th Aug 20202:44 pmRNSHolding(s) in Company
5th Aug 20204:42 pmRNSDirector/PDMR Shareholding
5th Aug 20204:41 pmRNSDirector/PDMR Shareholding
5th Aug 20204:41 pmRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSQ1 Trading Statement
28th Jul 202012:39 pmRNSHolding(s) in Company
10th Jul 20207:00 amRNSDirectorate Change
9th Jul 20205:19 pmRNSResult of AGM
6th Jul 20209:47 amRNSHolding(s) in Company
6th Jul 20209:47 amRNSHolding(s) in Company
19th Jun 20207:00 amRNSAmendment to Notice of AGM
10th Jun 20207:00 amRNSNotice of AGM
2nd Jun 20202:47 pmRNSDirector/PDMR Shareholding
2nd Jun 20202:39 pmRNSDirector/PDMR Shareholding
2nd Jun 20202:38 pmRNSDirector/PDMR Shareholding
2nd Jun 20202:38 pmRNSDirector/PDMR Shareholding
2nd Jun 20202:37 pmRNSDirector/PDMR Shareholding
29th May 20203:38 pmRNSHolding(s) in Company
27th May 20203:19 pmRNSDirector/PDMR Shareholding
26th May 20203:07 pmRNSHolding(s) in Company
22nd May 20209:58 amRNSDirector/PDMR Shareholding
21st May 20203:48 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSFull Year Results
13th May 20203:04 pmRNSHolding(s) in Company
13th May 202011:23 amRNSHolding(s) in Company
2nd Apr 20207:00 amRNSTrading Statement
26th Mar 202012:26 pmRNSDirectorate Change
24th Mar 20205:00 pmRNSHolding(s) in Company
24th Mar 202012:10 pmRNSCovid-19 Update
10th Mar 20204:19 pmRNSHolding(s) in Company
27th Feb 20203:31 pmRNSDirector/PDMR Shareholding
27th Feb 20203:30 pmRNSDirector/PDMR Shareholding
21st Feb 20206:26 pmRNSHolding(s) in Company
19th Feb 20204:28 pmRNSHolding(s) in Company
11th Feb 20203:22 pmRNSHolding(s) in Company
7th Feb 20207:00 amRNSDirectorate Change
6th Feb 202012:16 pmRNSDirector/PDMR Shareholding
31st Jan 20201:35 pmRNSHolding(s) in Company
29th Jan 202011:09 amRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Statement
13th Dec 20191:19 pmRNSDirector/PDMR Shareholding
13th Dec 20191:19 pmRNSDirector/PDMR Shareholding
11th Dec 20193:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.